ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

TARO Taro Pharmaceutical Industries Ltd

42.97
0.00 (0.00%)
28 Jun 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 156.67M130.5M139.2M146.59M158.89M148.2M157.15M164.94M
Operating Income 13.98M-6.82M1.28M9.27M-7.92M4.74M15.91M8.79M
Pre Tax Income 16.05M-4.91M9.17M17.9M5.44M17.66M33.34M26.23M
Net Income 14.08M-2.81M7.27M6.91M10.03M8.55M20.21M15.08M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT 14.42M-6.42M1.84M10.33M-7.53M5.31M17.73M10.98M
EBITDA 20.95M201k8.61M20.08M-30k12.35M23.28M17.01M
Year End 31 March 2024 20172018201920202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 879.39M661.91M673.57M644.77M548.97M561.35M572.95M629.18M
Operating Income 514.95M303.01M296.19M246.54M-413.78M63.47M17.71M21.51M
Pre Tax Income 560.8M292.37M356.85M298.04M-391.07M77.86M38.21M82.67M
Net Income 456.36M211.15M281.78M244.24M-386.65M58.27M25.45M53.87M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 11.2645.3557.3116.384-10.1941.550.6771.433
EBIT 526.16M304.9M298M249.55M-410.88M67.7M20.18M26.49M
EBITDA 530.06M319.51M314.79M267.92M-390.1M89.39M49.85M52.6M